The evolving role of real-world evidence in medical device approvals in the United States
Expert Rev Med Devices
.
2025 Jun;22(6):529-531.
doi: 10.1080/17434440.2025.2498458.
Epub 2025 Apr 29.
Authors
Swarnali Goswami
1
2
,
Prajakta P Masurkar
3
4
,
Aashrey Kaul
5
6
Affiliations
1
HEOR Department, Neurocrine Biosciences, Inc., San Diego, CA, USA.
2
Department of Pharmacy Administration, University of Mississippi, University, MS, USA.
3
Department of Pharmaceutical Health Outcomes and Policy, University of Houston, Houston, TX, USA.
4
HEOR Department, UCB, Atlanta, GA, USA.
5
Regulatory Affairs Department, Hycor Biomedical LLC, Garden Grove, CA, USA.
6
Department of Regulatory and Quality Sciences, University of Southern California, Los Angeles, CA, USA.
PMID:
40272412
DOI:
10.1080/17434440.2025.2498458
No abstract available
Keywords:
US FDA regulatory approval; evidence-based medicine; medical devices; real-world evidence.
Publication types
Editorial